All protocols
Cognitive / Nootropic

Selank Peptide Protocol & Dosing

Updated 2mo ago 6 min read 312+ helpful Calculator
Validity Score

Validity Score

34 Speculative
Evidence 24
Community 70
Completeness 71
Actionability 80
Coverage 100
Penalty -18

This score combines formal evidence, page completeness, calculator readiness, and community convergence.

What it is

Selank is a synthetic heptapeptide from tuftsin research.

Evidence boundary

Preclinical / limited human evidence.

Trial evidence

  • PMID 36322304 — Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
  • PMID 34396551 — Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.
  • PMID 32621722 — The Influence of Selank on the Level of Cytokines Under the Conditions of “Social” Stress.

Preparation and measurement

Reconstitution: 10 mg vial + 2 mL BAC = 5 mg/mL.

Concentration matches.

Reference schedule

Reference schedule
PhaseDoseDraw / measureFrequencyWeekly total
Weeks 1–2 (titration)300 mcg6 U (0.06 mL)Once daily (4 weeks on / 4 weeks off)2.1 mg/week
Weeks 3–4 (target)500 mcg10 U (0.1 mL)Once daily (4 weeks on / 4 weeks off)3.5 mg/week

Weeks 1–2 (titration)

Dose
300 mcg
Draw / measure
6 U (0.06 mL)
Frequency
Once daily (4 weeks on / 4 weeks off)
Weekly total
2.1 mg/week

Weeks 3–4 (target)

Dose
500 mcg
Draw / measure
10 U (0.1 mL)
Frequency
Once daily (4 weeks on / 4 weeks off)
Weekly total
3.5 mg/week

Weekly totals apply only during the active phase.

Titration rules

  • Light (300 mcg, once daily): Conservative starting dose.
  • Standard (600 mcg, twice daily): Common Russian clinical dose.
  • Cycle structure: 4 weeks active, 2 weeks off. Some protocols extend to 6-week cycles for severe anxiety.
  • Timing: Morning + early afternoon for twice-daily protocols. Avoid late-evening dosing — slight stimulant effect possible.

Cycle length and breaks

Some protocols extend to 6-week cycles for severe anxiety. The peptide does not produce dependence or sedation, making it different from benzodiazepine-class anxiolytics.

What to monitor

  • Stress tolerance claims in the literature
  • Nasal irritation if used intranasally
  • Headache or dizziness

Practical rules

  • Intranasal is the common route in the collected notes.
  • Rotate sites if used sub-Q.
  • Keep the language cautious.
Was this protocol helpful?
Share via
Supply & lot verification Availability and batch-linked COA records for Selank Peptide Protocol & Dosing are tracked with the current supplier listings. View availability & COA →

Dosing Calculator

10 mg + 2 mL BAC · week 1 300 mcg
LIVE CALCULATIONvolume / concentration / draw
RP–CALC–01
DRAW AMOUNT6 units0.06 mL · U-100
Draw 6 units, equivalent to 0.06 milliliters.
Concentration5 mg/mL
Selected dose0.3 mg (300 mcg) = 6 units
Enter a desired amount in milligrams or micrograms.
05 Standard amounts
1–10 mg · 0.5 mg steps
06 Suggested doses Select a row
1 unit = 0.01 mL on a U-100 syringe. Values retain decimal precision; visual marks are not silently snapped.
07 cycle summary

Vials required for Cycle

Estimate how much material you need for a full cycle, including cycle length and the number of cycles you plan to run.

Cycle total —
Total required vials —
Total reconstitution —
Total BAC water —
08 projected levels

How the draws stack up

A first-order model of depot absorption and elimination, run on the draws and cadence above. Pick the half-life from whatever your own source documents — this page does not assume one per compound. A planning sketch — not a prediction for any compound or any individual.

Half-life

Modelled level across the cycle. Each spike is one draw.

Accumulation—steady state vs one draw
Peak-to-trough—inside one interval
Steady state—about 4 half-lives
Draws modelled—at this cadence
Vial yieldat the selected amount
Draws per vial—
Lasts—
Volume used—
Limiting factor—
Water matrixsame vial, same amount
WaterStrengthDraw
0.5 mL——
1 mL——
2 mL——
3 mL——
5 mL——

Research Protocols

Keep up to date with latest protocols, updates and offers

An occasional email when a new protocol lands or an existing one is revised. No more than once a month.